Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
about
Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patientsReduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.Altered distribution of peripheral blood memory B cells in humans chronically infected with Trypanosoma cruziImmune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinoma.T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs.Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis.Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody.Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.Lactobacillus plantarum Strains Can Enhance Human Mucosal and Systemic Immunity and Prevent Non-steroidal Anti-inflammatory Drug Induced Reduction in T Regulatory Cells.CD70, a novel target of CAR T-cell therapy for gliomas.Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity
P2860
Q34639457-E86EC401-F4EF-4FD8-BBE3-BB40CC1751B7Q35174468-BCB85E5B-1105-4031-BDDE-27C7A1656BCDQ35222938-4CFFB980-437C-4F9F-A7A2-512B2806449AQ36199763-6E0EC52E-39BF-4477-9127-7957B9CBC93EQ36255816-F98DD2AE-B67E-4A38-A19D-EED991B3522BQ36359499-B1AB7D6D-6BEC-4F32-9647-EB894775643BQ36765422-16B77B5B-5651-4D23-B5BE-B2FC2F0DB7DCQ36983335-6DDE9592-AF8C-444C-B370-1EC4003BBBC6Q37658381-42B08D07-FEC3-4FB1-8E40-4FDEA2F1BECFQ39025444-5C13CFCF-CE4F-4B5C-9FE2-4B709B8D8EB5Q40533062-FDCDFE94-A727-4A4C-BD27-19915A8A7D94Q41526267-857E61A4-CE82-43A3-9D21-72838C06CCB6Q48223703-FC08C649-8DF2-4C80-AFD7-6872BE61B14FQ52672845-EDA2EB3C-BD2D-41B2-A503-A3C08A16F088Q57300170-0798C51E-481B-4C66-B78C-4EF30E0FE1E6
P2860
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
@ast
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
@en
type
label
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
@ast
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
@en
prefLabel
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
@ast
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
@en
P2093
P2860
P356
P1476
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.
@en
P2093
Alessandra Jales
Austin M Anderson
Caroline Jochems
David J Liewehr
James L Gulley
James W Hodge
Jeffrey Schlom
Jianping Huang
Kwong Y Tsang
Ravi A Madan
P2860
P304
P356
10.4049/JIMMUNOL.1300022
P407
P577
2013-05-15T00:00:00Z